Aaron Trimble

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Vanzacaftor–tezacaftor–deutivacaftor versus elexacaftor–tezacaftor–ivacaftor in individuals with cystic fibrosis aged 12 years and older (SKYLINE Trials VX20-121-102 and VX20-121-103): results from two randomised, active-controlled, phase 3 trials”.

Vanzacaftor–tezacaftor–deutivacaftor versus elexacaftor–tezacaftor–ivacaftor in individuals with cystic fibrosis aged 12 years and older (SKYLINE Trials VX20-121-102 and VX20-121-103): results from two randomised, active-controlled, phase 3 trials

The Lancet Respiratory Medicine(2025)10.1016/s2213-2600(24)00411-9

N/A

1.9DataRank · unranked

95 citations

Lael M. Yonker, F. Vermeulen, Dario Prais, Rachel W. Linnemann, Aaron Trimble +92 more

Drug exposure to infants born to mothers taking Elexacaftor, Tezacaftor, and Ivacaftor

Journal of Cystic Fibrosis(2021)10.1016/j.jcf.2021.12.004

N/A

0DataRank · unranked

82 citations

Christopher N. Fortner, Amanda Cotey, Charles R. Esther, Aaron Trimble, Bethany Collins

PRenatal mOdulator treatment to PrEvent CF complicaTions (PROTECT) workshop report

Journal of Cystic Fibrosis(2025)10.1016/j.jcf.2025.07.015

N/A

0DataRank · unranked

17 citations

Dara Riva, Yair J. Blumenfeld, John F. Engelhardt, Carmen Luna‐Paredes, Carlos Milla +17 more

Predicting Maternal and Fetal Exposures of Elexacaftor–Tezacaftor–Ivacaftor during Pregnancy through Physiologically Based Pharmacokinetic Models

Clinical Pharmacology & Therapeutics(2025)10.1002/cpt.3705

N/A

0DataRank · unranked

9 citations

Mary Hebert, Emily Fay, G. Turner, Patricia H. Eshaghian, Aaron Trimble +4 more